FDA Says Fusion’s Claims For Facial “Lift” Products Make Them Drugs
FDA expects Fusion Brands' written response to an April 24 warning letter within the next two weeks, the agency told "The Rose Sheet" May 30
FDA expects Fusion Brands' written response to an April 24 warning letter within the next two weeks, the agency told "The Rose Sheet" May 30